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Background: Primary ectopic atypical meningioma involving the renal hilum is rare. This is, to our knowledge, only the
second case report of a primary retroperitoneal meningioma and the first case of an atypical subtype in this location.
Case presentation: A 53-year-old Han Chinese man presented with a 2-year history of left-side flank pain. An
oval-shaped retroperitoneal mass was found in the left renal hilum on computed tomography, which was resected en
bloc along with the kidney via laparotomy. According to the World Health Organization criteria, the tumor was
histopathologically classified as a meningioma (Grade II, atypical). Five years later, the tumor recurred at the primary site
with a similar histopathology. The patient received palliative resection, followed by radiotherapy (4500 cGy in 25
fractions). No relapse was found at 6-month follow-up.
Conclusion: We describe the clinical, radiographic and histopathological features of an unusual case of aggressive
ectopic meningioma in the renal hilum. The patient presented with a massive retroperitoneal tumor without primary
cerebral or secondary metastatic lesions; the preoperative diagnosis was naturally confined to the common
retroperitoneal malignancies. This case is of interest to oncologists, because of both its rare location and aggressiveness;
it not only enriched the spectrum of primary ectopic meningioma, but also reminded us of potential recurrence of an
atypical meningioma. This case raises the issue of the etiology of such a rare tumor that needs further investigation,
and more importantly demands long-term follow-up result.
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Meningioma is a central nervous system (CNS) tumor
arising from arachnoidal or meningothelial cells [1]. It is
one of the most frequently diagnosed primary brain
tumors, comprising approximately one-third of CNS
tumors in adults in the United States [1]. Meningioma is
normally of slow-growing type, with the aggressive
lesion accounting for <10% of cases [1].
Despite being a common intracranial tumor, meningi-
oma has been reported to originate from unexpected sites
such as bone, scalp, paranasal sinuses, parotid gland, para-
pharyngeal space, mediastinum, lung, and even the abdo-
men [1,2]. Ectopic meningiomas are empirically defined as
primary tumors located in sites without arachnoidal cells,
ruling out local extension or metastasis. In 1996, Huszar* Correspondence: zhangwei@zjcc.org.cn
2Department of Urology, Zhejiang Cancer Hospital, Hangzhou, China, No.38
guangji Road, Gongshu District of Hangzhou, Zhejiang Province, Hangzhou,
China
Full list of author information is available at the end of the article
© 2014 Mao et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.et al. reported the first case of primary ectopic meningi-
oma in the retroperitoneum [2]. Here, we present a case
of primary meningioma in the renal hilum with atypical
presentation.
Case presentation
A 53-year-old man attended our clinic with a 2-year his-
tory of left-side, dull flank pain. The progressive pain was
aggravated by being in the recumbent position, without
groin-radiating pain. No emaciation, fever, hematuria or
CNS symptoms were present. Physical examination re-
vealed a large solid mass with an impalpable border in the
left upper quadrant of the abdomen. Abdominal com-
puted tomography (CT) scanning confirmed an irregular
mass with soft-tissue density near the left renal hilum, in-
vading the parenchyma. On imaging, the bulky mass had
transient heterogeneous enhancement, which was more
prominent in the center. There was no lymphadenopathy
or metastasis (Figure 1A and B). Intravenous urography
demonstrated that the enlarged left collecting system wasd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CT scanning and intravenous urography show the mass in the left renal hilum. The tumor displaced tissue near the renal hilum,
and invaded the parenchyma and renal vessels. A: The plain scanning of the tumor. B: The contrast-enhanced phase of imaging. C: The collecting
system of the affected kidney was compressed and distorted.
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ened calices; however, there were no visible filling defects
(Figure 1C). The routine laboratory tests were unremark-
able. The patient was initially diagnosed with primary
renal cancer.
During the operation, a well-defined, oval tumor mea-
suring 10.9 × 8.5 × 17.5 cm was found in the left renal
hilum. It infiltrated the renal parenchyma, encased the
renal vessels, and significantly displaced the pancreas
and splenic vessels. However, there were no enlarged
lymph nodes in the retroperitoneum. Radical nephrec-
tomy was performed, and the tumor was resected en
bloc without violation of the capsule. Frozen sections
showed that the tumor was renal spindle cell carcinoma.
The operation was not eventful and the patient was timely
discharged.Figure 2 Recurrent mass in the renal fossa. A: CT scanning demonstrate
the jejunum (arrow). B: delayed, mild enhancement was prominent in theHe was periodically followed up in our clinic. Multiple
CT scans of the abdomen were performed, with the
most recent being 2 years postoperatively. Five years
after surgery, an asymptomatic recurrent lesion was
identified attached to the psoas muscle and jejunum in
the left renal fossa. The patient was asymptomatic. On
CT scan, the tumor was shown to have delayed moderate
enhancement, which implies underdeveloped vasculature
(Figure 2). Doppler ultrasonography revealed moderate
blood flow within the hypoechoic mass (data not shown).
To identify other potential lesions, we performed cranio-
cerebral and thoracic CT scanning, which revealed no
mass lesion, displacement or bone destruction in the area.
The patient was readmitted for surgery. Intraopera-
tively, we found an 8.0 × 7.5-cm mass firmly attached to
the left psoas muscle, with infiltration to the proximals that the tumor attached closely to the psoas muscle and invaded
venous phase.
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resection of 10 cm of the involved proximal jejunum.
The second operation was complicated by sudden on-
set of persistent abdominal pain, nausea and vomiting at
postoperative day 7. Physical examination showed upper
abdominal distention without tenderness; the vital signs
were stable. Gastrointestinal imaging revealed small
bowel obstruction, presumably because of anastomotic
stricture (Figure 3). We placed a nasogastric tube and
later started total parenteral nutrition. After rehabilita-
tion, the patient was transferred to the medical oncology
ward and received local external radiotherapy (4500 cGy
in 25 fractions). No recurrence has been identified on
abdominal imaging 6 months after the second operation.
Microscopically, both specimens showed features of
multifocal necrosis (Figure 4A). Evaluation under a higher
magnification showed significant hypercellularity, with ep-
ithelioid tumor cells arranged in a whorl or sheet-like pat-
tern (Figure 4B). These polygonal cells were characterized
by abundant cytoplasm, vacuolated nuclei with fine chro-
matin and small nucleoli; the mitotic figures were evident
and were estimated to be 5–8 mitotic cells per 10 high-
power fields (Figure 4C). Immunohistochemically, the
tumor cells were extensively positive for epithelial mem-
brane antigen (EMA) and vimentin (Figure 4D1 and D2),
and locally for total cytokeratin (CK). The remaining
staining profiles were almost negative, including S-100,
HMB-45, bcl-2, melan-A, myelin basic protein (MBP),
neurofilament (NF), chromogranin A (CgA), C-kit, glial
fibrillary acidic protein, Glut1, CD21, CD23, CD31, CD34,
CD35, CD117, WT-1, smooth muscle actin, actin, inhibin-
α, Syn and progesterone receptor (PR). The cell prolifera-
tive index marker Ki67 was estimated at 15% (Figure 4E).
The histopathological diagnoses of both tumors wereFigure 3 Images of small bowl obstruction. Gastrointestinal imaging shatypical meningiomas [the World Health Organization
(WHO) 2007, Grade II], with the recurrent lesion invading
the intestinal tissue (Figure 4F). Given that no intracranial
or intraspinal lesion was identified, the patient was finally
diagnosed with primary ectopic atypical meningioma.
Discussion
The histological origin of ectopic meningioma is still
elusive. Some authors believe that the tumors might
derive from ectopic, misplaced, or migrating arachnoid
cells [3-5]. A recent analysis of oncogenesis have sug-
gested a different histogenesis between ectopic and CNS
lesions [6]. Some investigators have demonstrated that
the tumor may originate from perineurial cells or pluri-
potent mesenchymal cells [5]. Therefore, we speculate
that the meningioma in our case might have arisen from
a nest of trapped arachnoid cells in the retroperitoneum
during embryogenesis, or more likely from nerve sheath
cells, given the existing reports of renal schwannoma
involving the renal hilum [7].
An accurate preoperative diagnosis of ectopic men-
ingioma can be challenging. Despite radiographic simi-
larities between our case and aggressive intracranial
meningioma on retrospective review, including lobulation,
cyst formation, hemorrhage, necrosis, local invasion and
heterogeneity with brisk enhancement [8], there is a long
list of differential diagnosis of retroperitoneal tumors.
A preoperative differential diagnosis of benign and
malignant tumors at and around the renal bed can be
difficult. The topographic location of the tumor in our
case is reminiscent of renal cell cancer (RCC). As the
largest subtype, clear-cell RCC is a heterogeneous regu-
lar mass with destruction of the parenchyma and kidney
contours, and it shows strong contrast enhancement andowed a suspected obstruction at beginning of the jejunum.
Figure 4 Photomicrographs of histopathological examination. A: Necrotic foci appeared as an area filled with eosinophilic amorphous
material (pentagram) [hematoxylin–eosin (HE)-stained, original magnification × 4]. B: Epithelioid spindle-shaped cells form in a storiform and
sheet-like growth pattern (HE-stained, original magnification × 20). C: Fine structure of the tumor cells, and especially a typical mitotic figure
(yellow arrow) are clearly demonstrated (HE-stained, original magnification × 40). D1: Immunohistochemical staining of EMA was positive (original
magnification × 20). D2: Immunohistochemical staining of vimentin was positive (original magnification × 20). E: The Ki67 was estimated at 15%.
F: Infiltration of the tumor (arrow) into longitudinal intestinal muscle layer (arrowhead; HE-stained, original magnification × 4).
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RCCs tend to be homogeneous and undergo mild en-
hancement without frequent necrosis. After a RCC invades
the renal pelvis, it is often accompanied by hematuria.
Large RCCs often portend nodal disease, extension into
vessels, and distant metastasis.
Epithelioid angiomyolipoma, an unusual subtype of
renal angiomyolipoma, has been recently identified as a
potential malignancy. These non-fatty lesions invariably
appear as heterogeneous soft-tissue masses on CT; some
giant angiomyolipomas even exhibit local invasiveness and
lymph node metastasis. Enlarged vessels, hemorrhage, and
spontaneous kidney rupture are helpful for diagnosis if
identified [9].
Leiomyosarcomas are arguably the most common retro-
peritoneal sarcomas. These hypervascular malignancies,
mainly originating from vessel smooth muscle cells, are
more frequently located in the uterine or gastrointestinal
tracts. They appear as poorly circumscribed, lobulated
masses with iso/hypodensity and delayed circumferential
contrast enhancement on CT. They may also have exten-
sive necrosis, cystic degeneration, and hemorrhage. Im-
aging findings of compression, invasion, or obstruction of
the vena cava could be regarded as a characteristic of leio-
myosarcoma [10].
Liposarcomas, another group of common sarcomas of
the retroperitoneum, are considered relatively easy torecognize. However, the rare pleomorphic liposarcoma
may pose a challenge for differentiation because of a
non-fatty appearance. Extensive necrosis, hemorrhage
and metastasis are inadequate to discriminate them from
other soft-tissue malignancies [11].
Considering the non-pathognomonic imaging presen-
tations of this case and unexpectedly overlap in imaging
features of many retroperitoneal tumors, pathological
analysis through core biopsy is still a determinate diag-
nostic tool.
According to the WHO 2007 standards, meningioma
is histologically classified into three types: predominant
Grade I, benign tumors; and rare Grade II and III, ag-
gressive tumors. Histological Grade II meningioma, also
termed atypical meningioma, is estimated to account for
4.7–7.2% of the entity [12]. It is diagnosed when four or
more mitotic cells per 10 high-power fields and/or three
or more of the following: increased cellularity, small cells,
necrosis, prominent nucleoli, sheeting growth, and/or
brain invasion in an otherwise Grade I tumor [12].
Although the pathological guidelines are straightfor-
ward, the criterion resembles a series of carcinomas and
sarcomas that need differentiation. In this case, the
tumor should be distinguished from several retroperiton-
eal masses by means of immunohistochemistry and fluor-
escence in situ hybridization. The biphasic subtype of
synovial sarcoma exhibits epithelioid and mesenchymal
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EMA, vimentin, and CK. However, the cells grow in
nested acinar patterns, and more importantly, the charac-
teristic SYT-SSX fusion gene is diagnostic [13,14], which
was negative in our case (data not shown). Epithelioid
variant of hemangiopericytoma may also present with
positive staining of EMA and vimentin, but positive bcl-2
and CD34 are helpful for differentiation [15,16]. Soft-
tissue perineurioma, a rare subtype not arising from an
identifiable nerve, is found mainly in the superficial layers
of the limbs and trunk; its typical profile is strong positive
staining of EMA and CD34 [17].
The microscopic presentation and clinical features of
the tumor in our case were in line with the WHO 2007
Meningioma Classification (Grade II), and it could be
distinguished from the differential candidates above.
Despite a controversial marker to predict tumor progno-
sis, the relatively high level of Ki67 did indicate later
recurrence in our case [18]. In addition, it is noteworthy
that the PR staining in our case was negative. PR staining
positivity has been reported to appear mainly in classic
meningioma with good prognosis. Therefore, the negative
staining might suggest tumor aggressiveness [19].
The only definitive treatment for meningioma is cura-
tive resection. However, no successful precedent could
be found for treating retroperitoneal meningioma. In the
case reported by Huszar et al., the patient relapsed
6 months after surgical resection and survived for only
2 years under chemotherapy [2]. Our case was milder,
but it still demonstrates certain aggressiveness including
infiltration into the muscle and intestine, and more ex-
tensive positive markers (EMA and vimentin) and necro-
sis. Finally, the patient was recommended to receive
radiotherapy, the standard adjuvant therapy for inoper-
able or recurrence-prone intracranial meningioma [20].
The outcome remains to be seen.
Conclusion
To the best of our knowledge, this is only the second case
report of a primary retroperitoneal meningioma and the
first case of an atypical subtype in this location. Like the
previously reported one, our case presented with invasive-
ness and gross volume, which warranted regular examin-
ation and timely treatment. Considering its rarity and
non-pathognomonic presentation, the best method of pre-
operative diagnosis might be core biopsy. Surgical resec-
tion combined with adjuvant radiotherapy may be an
alternative treatment, but urgently needs assessment.
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